Trials / Recruiting
RecruitingNCT07328282
Comparative Effects Between ELDOA and Spinal Mobilization With Limb Movement in Lumbar Radiculopathy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Foundation University Islamabad · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study examines the comparative effects of ELDOA and Spinal Mobilization with Leg Movement (SMWLM) on lumbar radiculopathy
Detailed description
Participants were randomly assigned into two groups: Group A, which performed structured ELDOA exercises targeting spinal decompression and postural alignment Group B, which received SMWLM interventions focusing on spinal mobilization combined with controlled leg movements. Pain, functional disability, and lumbar range of motion were measured using Visual Analog Scale, Oswestry Disability Index, and bubble inclinometer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ELDOA | Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group A will receive ELDOA in addition to standard physiotherapy. Each position will be sustained for at least one minute, with gradual progression to the full posture as flexibility and control improve. |
| PROCEDURE | Spinal Mobilization with Limb Movement - SMWLM | Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group B will receive spinal mobilization combined with limb movement along with standard physiotherapy. The technique will be repeated three times. |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-12-30
- Completion
- 2026-01-15
- First posted
- 2026-01-09
- Last updated
- 2026-01-09
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07328282. Inclusion in this directory is not an endorsement.